Favourable current prognosis after HLA-identical bone marrow transplantation for children with acquired severe aplastic anaemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center;Tegenwoordig gunstige prognose na HLA-identieke beenmergtransplantatie bij kinderen met verworven ernstige aplastische anemie; evaluatie van 30 jaar beenmergtransplantaties in het Leids Universitair Medisch Centrum

Nederlands Tijdschrift voor Geneeskunde

Volumn 146, Issue 33, 2002, Pages 1542-1546

  Van Steekelenburg, M ^a   Van Weel Sipman, M H ^a   Zwinderman, A H ^a   Hoogerbrugge, P M ^a   Vossen, J M J J ^a   Egeler, R M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; HLA ANTIGEN; METHOTREXATE; PROCARBAZINE; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HUMAN; MORBIDITY; PROGNOSIS; PROPHYLAXIS; SURVIVAL RATE; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; EVALUATION; FEMALE; FOLLOW UP; GRAFT SURVIVAL; IMMUNOLOGY; INFANT; MALE; MORTALITY; NUCLEAR FAMILY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; ENGLISH ABSTRACT; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HLA ANTIGENS; HUMAN; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; NUCLEAR FAMILY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; HUMANS;

EID: 0037125562     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. The pathophysiology of acquired aplastic anemia
2. Severe aplastic anemia: A prospective study of the effect of early marrow transplantation on acute mortality
3. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors
4. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia
5. Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: A report from the EBMT SAA Working Party
6. What is the most effective treatment of children with severe aplastic anemia who lack a matched sibling donor?
7. Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy - The European group for Blood and Marrow Transplantation experience
8. Long-term outcome after marrow transplantation for severe aplastic anemia
9. Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: Changing impact of risk factors
10. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in four centers
11. Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: Results of a GITMO/EBMT randomized trial
12. Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis)
13. Graft rejection and second bone marrow transplants for acquired aplastic anaemia: A report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group
14. Marrow transplantation for severe aplastic anemia: Methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease